Evidence level: C
在真滞后量为零的世界里,按三种病种各自的常规随访表算出来的 Δτ,会自己排出一条 “DoC 领先最大、卒中居中、TBI 最小” 的梯度——而这条梯度恰好就是我们要检验的假设。
正文
上一轮(#554)的结论是:把「α 网络重构先于功率恢复」写成 Δτ = τ_power − τ_net 这一个标量,本身就撑不住——同一真值能反推出十几组时间常数组合,零相干地板还随记录段数漂移。这一轮任务卡把矛头转向跨病种:DoC(弥漫性、重构领先幅度最大)、卒中(局灶性)、TBI(弥漫性但常有局灶成分)三组人群,在同一协议下 Δτ 的分布是否随损伤性质呈现可预测的梯度。
先看文献侧的家底。弥漫与局灶在脑电层面确有差别,这一点不假:PMID 29141595 用一组时序特征把 40 例意识水平下降患者的局灶性与弥漫性病因分到 76% 的准确率——这是真实的分类能力。但它做的是”病因分类”,不是”恢复曲线”。逐病种再看:PMID 29635028 跟踪 13 例亚急性皮质下卒中患者,在 0/20/40/60/180 天五点测 TMS-EEG,报的是 α 振荡功率在 40 天升高,没有网络层读数;PMID 22361265 跟踪 49 例轻型脑外伤,在 7/15/30 天与 6/12 月五轮测 α 功率抑制幅度,报它能预测恢复速率(r²=0.609),也只有功率层;PMID 30186220 用 4 例个案报 α 网络中心性跟踪行为改善、delta 功率持续偏高对应不改善,有网络层但 n=4;PMID 41395158 在 50 例 TBI 上对比 30 天与 180 天,发现 α 相对功率下降、delta 上升——方向和”恢复即 α 上升”正好相反。结论很清楚:没有任何一项研究在同一批人身上同时报出网络重构与功率恢复的两条曲线。Δτ 在真实数据里至今一次都没被直接测过。这不是数据稀缺,是没有一篇论文把它当成主终点。
所以现在要问的,不是”梯度长什么样”,而是”Δτ 这个数在跨病种之间到底能不能比”。我用仿真把三个障碍逐个摆了摆。
第一刀:τ 的估计被随访表决定。 真曲线若是 y = C + A·exp(−t/30),而分析者按常规做法假设曲线会归零(忽略渐近项 C),两点法给出的 τ̂ 就完全跑偏:C=0.3 时,间隔 180 天给 123 天、730 天给 498 天;C=0.6 时给 184 天与 744 天——真值都是 30 天。换句话说,”领先多少天”里有相当一部分,来自你采了哪几个时间点、以及你让不让曲线归零。可辨识性也印证这一点:只有 2 个采样点时,落在真值 ±20% 内的比例是 8–15%(几乎等于瞎猜);3 个点、末次 90 天时能到 72%,但末次拉到 365 天反而掉到 4%、730 天是 0%——跨度太长时渐近项把曲线”压平”,τ 反而不可辨识。要稳,需要 6 个点以上且末次在半年附近(98.3%)。
第二刀:局灶损伤被空间平均稀释。 全局指标只反映受累通道的占比 f。同一真 τ=30 天、噪声固定,f=1.00 时 τ̂ 的标准差是 2.8 天;f=0.50 是 5.3 天;f=0.25 是 12.4 天;f=0.10 时飙到 87.4 天,落在 ±30% 内只有 31.5%。也就是说局灶病种天生更难拟合、方差更大——但”方差大”会被读者读成”变化不明显”,而不是”测不准”。
第三刀,也是最要命的一刀:假梯度。 把三种病种的真值全部设成同一个(τ_net = τ_power = 35 天,真 Δτ 恒等于 0),只让各自沿用文献里常见的采样几何——DoC 用低基线(0.10)加稀疏长随访(0/180/365/730),卒中用中等基线(0.45)加半年内密网格,TBI 用较高基线(0.85)加 0/30/60/90/180/365。结果是:DoC 的 Δτ 均值 +12.5 天、Δτ 绝对值超过 20 天的比例 71%;卒中 +0.7 天、7%;TBI 恰好 0 天、0%。病种标签能解释 Δτ 方差的比例(组间方差占比)只有 1.1%——分母全是采样几何贡献的噪声,而偏倚的方向恰与假设一致:预测”DoC 领先最大”的那一端,被自动算成了领先最大。这条最危险:因为结果”符合预测”,审稿人不会怀疑,反而会当成支持。
出路是统一的协议,不是更大的样本。把网格锁成 0/14/28/60/90/150/210 七天七点后,真 Δτ=15 天时单例检出(Δτ̂ 绝对值超过 8 天且同号)比例 88.8%、SD 5.6 天;真 Δτ=0 时假阳性只有 3.8%。此时要检出”病种 × Δτ”的交互项,组内 SD=7 天、目标差 10 天,每组约 8 例即可——门槛不在人少,在协议不齐。另有一条前置条件:读数口径必须锁死,同一数据换一种网络度量(口径噪声 SD=0.10),两口径的 τ̂ 之差 95% 区间是 −29.6 到 +26.0 天,比多数病种间的真差还大。
文献侧还有一处真正的冲突要摆出来:PMID 32795964 在两年纵向 hdEEG 上发现,网络指标的变化速率能预测后续 CRS-R 的变化,且优于临床指标——支持”网络先于行为”;但 PMID 33855295 在 18 例急性创伤后无反应患者上,α 网络复杂度只与当时的临床状态相关,与 3 个月、6 个月的结局都不显著,能改进结局预测的反而是最简单的平均相对 α 功率。两篇都不弱,都不该被挑剩一边。这条冲突不解决,”重构先于功率”就还只是半个结论。
放到易学的语境里看,这里涉及的是”象—数—应”三段的老要求:象(弥漫还是局灶)在 PMID 29141595 那里已有脑电层的分辨力,但”数”(Δτ 这个具体数值)目前在跨病种间不可辨识,”应”(结局预测)就还挂不上去。古法讲同一象在不同时位给出不同数,本来就不要求一个恒定函数;现代研究反过来要求数先可辨识、再谈应。这一轮的裁决是:先把数的可辨识性做实,象数到应的链条才有意义,否则所谓梯度只是自己采样表的形状。
证据与局限
已验证: 弥漫性与局灶性脑损伤在脑电时序特征上可区分(PMID 29141595,40 例,分类准确率 76%);α 网络指标能跟踪意识与行为的纵向变化(PMID 32795964 两年纵向 hdEEG;PMID 30186220 四例个案);轻型脑外伤的 α 功率抑制幅度可预测恢复速率(PMID 22361265,49 例,r²=0.609)。
部分验证: “网络重构先于行为/功率恢复”方向上有支撑(PMID 32795964 报 hdEEG 变化速率预测下一次 CRS-R 变化且优于临床指标),但同期研究给出反向结果(PMID 33855295:网络特征与 3/6 月结局不显著,仅平均相对 α 功率改进预测);TBI 侧甚至报出 α 相对功率随恢复下降(PMID 41395158,50 例,30 天 vs 180 天)。方向本身尚未收敛。
待验证: 三病种 Δτ 的跨病种梯度(DoC > 卒中 > TBI)从未被直接测量——没有任何一项研究在同批受试者上同时报出网络重构与功率恢复两条曲线;本文基于仿真提出的”梯度可被采样几何完整伪造”这一裁决,需在多中心统一协议的前瞻数据上验证。
相关阅读
证据等级: C
参考文献: PMID 39417105, PMID 29141595, PMID 29635028, PMID 22361265, PMID 30186220, PMID 41395158, PMID 32795964, PMID 33855295, PMID 25329398, PMID 28970969
L1 网络状态:该主题尚未进入 L1 对应网络——EDGE_TABLE_science-yixue.md(63 行)概念表检索「重构/功率/恢复/时间常数/滞后」仅命中「EEG 72 篇 A 级 5 篇 代表 PMID 19299197」与「脑电 72 篇 A 级 12 篇 代表 PMID 21909024」两行节点级登记,均为概念-文章计数,无承载「网络重构与功率恢复的时序解耦」或「跨病种滞后量可比性」的边;CORRESPONDENCE_NETWORK.md(2875 行)检索「重构/功率恢复/时间常数/τ/滞后」无一条落在恢复时序,最近邻为 E-004(土↔脾)段 KB-487「脾收缩 τ:从找文献转为重分析」与 E-061 段「呼吸→心搏相位延迟 ≈0.9 s 可当常数(固定体位下近似常数,跨体位约 10% 量级漂移)」——前者是单一器官的收缩时间常数、后者是稳态相位滞后,均不涉及「同一受试者身上两个读数层的恢复速率差」。
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
Is the \”DoC Leading Maximum\” Gradient a True Signal or a Reflection of Sampling Geometry: A Comparative Verdict Reconstructing Power Lag Across Three Diseases
Evidence level: C
In a world where the true lag is zero, the Δτ calculated from each condition’s standard follow-up schedule would naturally sort itself into a “DoC leading largest, stroke intermediate, TBI smallest” gradient—which is precisely the hypothesis we aim to test.
Body
The conclusion from the previous round (#554) is that expressing “network reconstruction precedes power recovery” as a single scalar, Δτ = τ_power − τ_net, is insufficient on its own. A single true value can yield dozens of combinations of time constants, and the zero-coherence floor drifts with the number of recording segments. This round’s task card shifts the focus to cross-diagnostic groups: DoC (diffuse, largest reconstruction lead), stroke (focal), and TBI (diffuse but often with focal components). Under the same protocol, does the distribution of Δτ show a predictable gradient based on injury nature?
First, reviewing the literature: diffuse and focal do indeed differ at the EEG level. PMID 29141595 uses temporal features to classify focal vs. diffuse etiologies in 40 patients with decreased consciousness, achieving 76% accuracy—this is genuine classification ability. However, it performs “etiology classification,” not “recovery curves.” Examining each diagnosis individually: PMID 29635028 tracks 13 subacute subcortical stroke patients, measuring TMS-EEG at days 0/20/40/60/180, reporting increased α oscillation power at day 40, with no network-layer readings; PMID 22361265 tracks 49 mild TBI patients, measuring α power suppression amplitude at days 7/15/30 and months 6/12, reporting it predicts recovery rate (r²=0.609), but only at the power layer; PMID 30186220 uses 4 cases, reporting α network centrality tracking behavioral improvement and sustained elevated delta power corresponding to non-improvement, having network layers but n=4; PMID 41395158 compares day 30 vs. day 180 in 50 TBI patients, finding decreased relative α power and increased delta—direction opposite to “recovery as α increase.” The conclusion is clear: no study reports both network reconstruction and power recovery curves on the same cohort. Δτ has never been directly measured in real data. This is not data scarcity; it is that no paper has made it the primary endpoint.
So the question now is not “what does the gradient look like,” but “can Δτ be compared across diagnostic groups?” I simulated three obstacles individually.
First cut: τ estimation is determined by the follow-up schedule. If the true curve is y = C + A·exp(−t/30), and the analyst assumes the curve returns to zero (ignoring asymptote C) using standard two-point estimation, τ̂ becomes completely biased: with C=0.3, intervals of 180 days yield 123 days and 730 days yield 498 days; with C=0.6, they yield 184 days and 744 days—the true value is always 30 days. In other words, much of “how many days ahead” comes from which sampling points were chosen and whether the curve is allowed to return to zero. Identifiability confirms this: with only 2 sampling points, the proportion falling within ±20% of the true value is 8–15% (almost random guessing); with 3 points and final measurement at day 90, it reaches 72%, but pulling the final point to day 365 drops it to 4%, and day 730 to 0%—when the span is too long, the asymptote flattens the curve, making τ unidentifiable. Stability requires 6+ points with the final measurement near six months (98.3%).
Second cut: focal injury is diluted by spatial averaging. Global metrics only reflect the proportion f of affected channels. For the same true τ=30 days and fixed noise, the standard deviation of τ̂ is 2.8 days when f=1.00, 5.3 days when f=0.50, 12.4 days when f=0.25, and 87.4 days when f=0.10, with only 31.5% falling within ±30%. Thus, focal diagnoses are inherently harder to fit and have higher variance—but “high variance” will be read by readers as “little change,” not “unreliable.”
Third cut, and most critical: false gradients. Setting the true values for all three diagnoses to the same (τ_net = τ_power = 35 days, so true Δτ always equals 0), but letting each follow the common sampling geometry from literature: DoC uses low baseline (0.10) plus sparse long follow-up (days 0/180/365/730); stroke uses medium baseline (0.45) plus dense grid within six months; TBI uses higher baseline (0.85) plus days 0/30/60/90/180/365. The result: DoC’s mean Δτ is +12.5 days, with 71% exceeding 20 days in absolute value; stroke is +0.7 days, with 7%; TBI is exactly 0 days, with 0%. The proportion of Δτ variance explained by diagnostic label (ratio of between-group variance) is only 1.1%—the denominator is entirely noise from sampling geometry, and the bias direction exactly matches the assumption: the end predicted to lead most (“DoC leads most”) is automatically calculated as leading most. This is the most dangerous: because results “match predictions,” reviewers will not suspect, but instead treat it as support.
Evidence and Limitations
The unified protocol is not achieved by increasing sample size. By locking the grid to 0/14/28/60/90/150/210 seven-day cycles, the single-case detection rate for true Δτ=15 days (where |Δτ̂| exceeds 8 days and shares the same sign) reaches 88.8%, with a standard deviation (SD) of 5.6 days; for true Δτ=0, false positives are only 3.8%. To detect the “disease × Δτ” interaction, an intra-group SD of 7 days and a target difference of 10 days require approximately 8 cases per group—the threshold is not insufficient people, but incomplete protocol alignment. A prerequisite condition: the reading scale must be fixed; switching network metrics on the same data (scale noise SD=0.10) yields a 95% confidence interval for the difference in τ̂ between scales of −29.6 to +26.0 days, larger than true differences between most diseases.
A genuine conflict in the literature must be acknowledged: PMID 32795964 found, over two years of longitudinal hdEEG, that the rate of change in network metrics predicts subsequent CRS-R changes better than clinical indicators—supporting “network precedes behavior”; yet PMID 33855295, on 18 acute trauma unresponsive patients, found α-network complexity correlates only with current clinical status, not 3- or 6-month outcomes, while the simplest mean relative α power improved outcome prediction. Both studies are robust; neither should be discarded. Without resolving this conflict, “reconstruction precedes power” remains only half a conclusion.
Within the Yijing Studies framework, this involves the traditional triad of “image-number-response” (xiàng-shù-yìng): image (diffuse vs. focal) has EEG-level resolution per PMID 29141595, but number (the specific Δτ value) remains unidentifiable across diseases, so response (outcome prediction) cannot attach. Ancient methods allowed the same image to yield different numbers at different temporal positions, without requiring a constant function; modern research instead demands the number be identifiable before discussing response. This round’s verdict is: first solidify the identifiability of the number, then the image-number-to-response chain becomes meaningful; otherwise, so-called gradients are merely shapes of one’s own sampling table.
Evidence and Limitations
Verified: Diffuse and focal brain injuries are distinguishable by EEG temporal features (PMID 29141595, n=40, classification accuracy 76%); α-network metrics track longitudinal changes in consciousness and behavior (PMID 32795964, two-year longitudinal hdEEG; PMID 30186220, four case studies); the amplitude of α-power suppression in mild traumatic brain injury predicts recovery rate (PMID 22361265, n=49, r²=0.609).
Partially Verified: Support exists for the direction “network reconfiguration precedes behavioral/power recovery” (PMID 32795964 reports hdEEG change rate predicting the next CRS-R change, outperforming clinical markers), yet concurrent studies report the opposite result (PMID 33855295: network features not significantly associated with 3/6-month outcomes, only mean relative α-power improvement predicts); TBI studies even report a decline in relative α power with recovery (PMID 41395158, n=50, 30 days vs. 180 days). The direction itself has not yet converged.
Pending Verification: The cross-disease gradient of Δτ (DoC > stroke > TBI) has never been directly measured—no study has simultaneously reported both network reconfiguration and power recovery curves on the same cohort. This verdict, based on simulation that “the gradient can be entirely fabricated by sampling geometry,” requires verification against prospective data from a unified multi-center protocol.
Related Reading
- Universal validation of alpha network reorganization preceding power recovery
- A single Δτ cannot support three disease categories: sign readout and artifact of amplitude-structure recovery time constants
- Multimodal frequency signature drift-recovery asymmetry index
- Research pool: spatiotemporal frequency topology
Evidence level: C
References: PMID 39417105, PMID 29141595, PMID 29635028, PMID 22361265, PMID 30186220, PMID 41395158, PMID 32795964, PMID 33855295, PMID 25329398, PMID 28970969
L1 network status: This topic has not yet entered the corresponding L1 network—EDGE_TABLE_science-yixue.md (63 rows). Concept table retrieval for “reorganization/power/recovery/time constant/latency” only hit two node-level entries: “EEG 72 A-level papers, 5 representative PMID 19299197” and “brain EEG 72 A-level papers, 12 representative PMID 21909024”. Both are concept-article counts, lacking edges that carry “temporal decoupling of network reorganization and power recovery” or “cross-disease latency comparability”. CORRESPONDENCE_NETWORK.md (2875 rows) retrieval for “reorganization/power recovery/time constant/τ/latency” yielded no entries on recovery timing; the nearest neighbors are E-004 (Earth ↔ Spleen) segment KB-487 “Spleen contraction τ: shifting from literature search to reanalysis” and E-061 segment “Breath-to-heartbeat phase delay ≈0.9 s usable as a constant (fixed posture approximates a constant, cross-posture drift ~10% magnitude)”—the former is the contraction time constant of a single organ, the latter is steady-state phase lag; neither involves “recovery rate difference between two reading layers on the same subject.”
Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.
Leave a Reply